Medication use among the oldest old in the Faroe Islands—A national cross‐sectional study

Abstract

AbstractAging is often associated with an increasing number of comorbidities that warrant use of multiple drugs which increases the use of potentially inappropriate medications (PIMs), drug–drug interactions (DDIs) and drug‐related problems (DRPs). The aim is to assess the prevalence of polypharmacy, PIMs, DDIs and DRPs among Faroese residents aged ≥90 years. In this population‐based cross‐sectional study, 494 individuals ≥90 years were invited and 298 (60%) participated. A pharmacist‐led medication review was performed based on self‐information, electronic patient journal and the Faroese Prescription Registry. The prevalence of polypharmacy was 74% with no sex‐difference. Approximately 60% of participants used PIMs, primarily benzodiazepines and proton pump inhibitors, the latter being a frequently implicated medication in DRPs. Opioid use was low compared with other Nordic studies. DRPs were observed for 79% with discrepancies in the medication lists as the most common cause, and DDIs were identified for 47% of participants, mostly moderately clinically relevant DDIs. In conclusion, the medication use among the oldest old Faroese resembled that in other Nordic countries with a high prevalence of polypharmacy and use of PIMs, especially PPIs and benzodiazepines. However, no sex‐difference was noted in medication use and the use of opioids was low.